737 related articles for article (PubMed ID: 20884914)
1. Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation.
Pediconi F; Padula S; Dominelli V; Luciani M; Telesca M; Casali V; Kirchin MA; Passariello R; Catalano C
Radiology; 2010 Dec; 257(3):653-61. PubMed ID: 20884914
[TBL] [Abstract][Full Text] [Related]
2. Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI?
Linda A; Zuiani C; Furlan A; Lorenzon M; Londero V; Girometti R; Bazzocchi M
AJR Am J Roentgenol; 2012 Feb; 198(2):272-80. PubMed ID: 22268168
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
[TBL] [Abstract][Full Text] [Related]
4. MR imaging-guided 9-gauge vacuum-assisted core-needle breast biopsy: initial experience.
Orel SG; Rosen M; Mies C; Schnall MD
Radiology; 2006 Jan; 238(1):54-61. PubMed ID: 16304093
[TBL] [Abstract][Full Text] [Related]
5. Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ.
Friedlander LC; Roth SO; Gavenonis SC
Radiology; 2011 Nov; 261(2):421-7. PubMed ID: 21900618
[TBL] [Abstract][Full Text] [Related]
6. High-risk breast lesions at imaging-guided needle biopsy: usefulness of MRI for treatment decision.
Londero V; Zuiani C; Linda A; Girometti R; Bazzocchi M; Sardanelli F
AJR Am J Roentgenol; 2012 Aug; 199(2):W240-50. PubMed ID: 22826427
[TBL] [Abstract][Full Text] [Related]
7. Imaging-guided core needle biopsy of papillary lesions of the breast.
Rosen EL; Bentley RC; Baker JA; Soo MS
AJR Am J Roentgenol; 2002 Nov; 179(5):1185-92. PubMed ID: 12388496
[TBL] [Abstract][Full Text] [Related]
8. Ductal enhancement on MR imaging of the breast.
Liberman L; Morris EA; Dershaw DD; Abramson AF; Tan LK
AJR Am J Roentgenol; 2003 Aug; 181(2):519-25. PubMed ID: 12876038
[TBL] [Abstract][Full Text] [Related]
9. MR imaging in probably benign lesions (BI-RADS category 3) of the breast.
Gökalp G; Topal U
Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732
[TBL] [Abstract][Full Text] [Related]
10. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
[TBL] [Abstract][Full Text] [Related]
11. Frequency, upgrade rates, and characteristics of high-risk lesions initially identified with breast MRI.
Strigel RM; Eby PR; Demartini WB; Gutierrez RL; Allison KH; Peacock S; Lehman CD
AJR Am J Roentgenol; 2010 Sep; 195(3):792-8. PubMed ID: 20729462
[TBL] [Abstract][Full Text] [Related]
12. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK
Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
[TBL] [Abstract][Full Text] [Related]
13. [Papillary lesions of the breast: diagnostic imaging and contribution of percutaneous needle biopsy with 14G needle].
Bazzocchi M; Berra I; Francescutti GE; Del Frate C; Zuiani C; Puglisi F; Di Loreto C
Radiol Med; 2001 Jun; 101(6):424-31. PubMed ID: 11479438
[TBL] [Abstract][Full Text] [Related]
14. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
Masood S; Loya A; Khalbuss W
Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
[TBL] [Abstract][Full Text] [Related]
15. Histologic work-up of non-palpable breast lesions classified as probably benign at initial mammography and/or ultrasound (BI-RADS category 3).
Gruber R; Jaromi S; Rudas M; Pfarl G; Riedl CC; Flöry D; Graf O; Sickles EA; Helbich TH
Eur J Radiol; 2013 Mar; 82(3):398-403. PubMed ID: 22429299
[TBL] [Abstract][Full Text] [Related]
16. Handling a high relaxivity contrast material for dynamic breast MR imaging using higher thresholds for the initial enhancement.
Carbonaro LA; Verardi N; Di Leo G; Sardanelli F
Invest Radiol; 2010 Mar; 45(3):114-20. PubMed ID: 20065856
[TBL] [Abstract][Full Text] [Related]
17. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.
Kuhl CK; Schild HH; Morakkabati N
Radiology; 2005 Sep; 236(3):789-800. PubMed ID: 16118161
[TBL] [Abstract][Full Text] [Related]
18. Dynamic contrast-enhanced breast MR imaging in men: preliminary results.
Morakkabati-Spitz N; Schild HH; Leutner CC; von Falkenhausen M; Lutterbey G; Kuhl CK
Radiology; 2006 Feb; 238(2):438-45. PubMed ID: 16371581
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous imaging-guided core breast biopsy: 5 years' experience in a community hospital.
Margolin FR; Leung JW; Jacobs RP; Denny SR
AJR Am J Roentgenol; 2001 Sep; 177(3):559-64. PubMed ID: 11517047
[TBL] [Abstract][Full Text] [Related]
20. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.
Sardanelli F; Fausto A; Esseridou A; Di Leo G; Kirchin MA
Invest Radiol; 2008 Apr; 43(4):236-42. PubMed ID: 18340247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
